You are here Home Resources Handbook tables Handbook tables Table. Recommendations for immunisation of infants and children aged <2 years using meningococcal B vaccine Listen Print Share Twitter Facebook Email Medical conditions are specified in List. Specified medical conditions associated with increased risk of invasive meningococcal disease. Age at start of vaccine course MenB vaccine brand Dose requirements for healthy people (without any medical conditions associated with increased risk of invasive meningococcal disease) 6 weeks to 11 months Bexsero 3 doses (8 weeks between 1st and 2nd doses; 3rd dose at 12 months of age or 8 weeks after 2nd dose, whichever is later) 12–23 months Bexsero 2 doses (8 weeks between doses) Page history Last updated 7 December 2022 Last reviewed 7 December 2022 Related diseases Meningococcal disease Is there anything wrong with this page?
